Galmed Pharmaceuticals GLMD
NASDAQ GLMD
$4.30 -0.26 (-5.59%)
As of: Aug 21, 2026 · 3:44 PM EDT

Galmed Pharmaceuticals (GLMD) Property, Plant & Equipment (Net) (2013 - 2025)

Galmed Pharmaceuticals (GLMD) Property, Plant & Equipment (Net) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Galmed Pharmaceuticals 2.31 Mn -9.57 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 56,000.00
Dec 31, 2025 56,000.00
Dec 31, 2024 70,000.00
Dec 31, 2024 70,000.00
Mar 31, 2024 74,000.00
Mar 31, 2024 74,000.00
Dec 31, 2023 83,000.00
Dec 31, 2023 83,000.00
Sep 30, 2023 89,000.00
Sep 30, 2023 89,000.00
Jun 30, 2023 97,000.00
Jun 30, 2023 97,000.00
Mar 31, 2023 5,000.00
Mar 31, 2023 5,000.00
Dec 31, 2022 114,000.00
Dec 31, 2022 114,000.00
Sep 30, 2022 122,000.00
Sep 30, 2022 122,000.00
Jun 30, 2022 130,000.00
Jun 30, 2022 130,000.00